drugset / Trial / NCT00165555

Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma

NCT00165555

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study it to determine the safety and maximally tolerated dose (MTD) of cisplatin administered in the operating room and put into the chest and abdomen for one hour. We are also looking at the effects of heating the chemotherapy to a temperature of 42 degrees celsius.

Timeline

Start
1999-08
Primary completion
2002-04
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified Other
Background Sodium Thiosulfate Diagnostic / imaging agent Intravenous